Biogen Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Biogen Inc. is a biotechnology company that specializes in treating neurological diseases. Through research, development, and distribution, this company helps people access treatments for disorders including Alzheimer’s, Multiple Sclerosis, and Spinal Muscular Atrophy.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Biogen Inc. has earned a spot in our top 100. The greatest contributors to this positive outcome are Healthcare R&D ($41.0 B), Pharmaceuticals ($39.3 B), and Economic Value ($3.8 B). The value associated with Healthcare R&D and Pharmaceuticals includes the annual impact of an estimated 1,500,000 additional years lived by people worldwide. This firm can increase its Humankind Value by addressing Greenhouse Gases (-$870.5 M) and Air Pollution (-$110.3 M). Healthcare R&D, Pharmaceuticals, Economic Value, Greenhouse Gases, and Air Pollution are attributed to this company as a result of its direct business activities.